NYSE · Medical - Equipment & Services

HIMS (HIMS) Stock

$30.24 +7.67% NYSE: HIMS Healthcare

Valuation

MetricValue
Price$30.24
Market Cap$6.75B
P/E Ratio44.00
P/B Ratio9.11
P/S Ratio2.08
EPS (TTM)$0.51
52-Week High$70.43
52-Week Low$13.74
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE23.66%
ROA5.94%
ROCE19.59%
Gross Margin4.51%
Operating Margin4.51%
Net Margin-0.56%
Debt/Equity2.54
Current Ratio1.90

Annual Financials (USD)

Metric20212022202320242025
Revenue$272.0M$527.0M$872.0M$1.5B$2.3B
Operating Profit$-115.0M$-69.0M$-29.0M$62.0M$106.0M
Net Profit$-108.0M$-66.0M$-24.0M$126.0M$128.0M
EPS$-0.58$-0.32$-0.11$0.53$0.51
Op Margin-42.3%-13.0%-3.4%4.2%4.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$421.0M$366.0M$441.0M$708.0M$2.2B
Total Liabilities$86.0M$55.0M$97.0M$231.0M$1.6B
Cash$72.0M$47.0M$97.0M$221.0M$229.0M
Borrowings$5.0M$5.0M$10.0M$11.0M$1.3B

Latest News

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds StockStory · Jul 22, 2026 HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed ‘More Qualified And Less Conflicted’ Stocktwits · Jul 22, 2026 HIMS: Lowering target price to $34.00 Argus Research · Jul 22, 2026 HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting Stocktwits · Jul 21, 2026 Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company Business Wire · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-27.0M$73.0M$251.0M$300.0M
Investing Cash Flow$-161.0M$27.0M$-39.0M$-72.0M$-1.3B
Financing Cash Flow$-39.0M$-33.0M$-11.0M$-108.0M$-207.0M
Net Cash Flow$44.0M$-25.0M$50.0M$124.0M$8.0M
Free Cash Flow$-39.0M$-34.0M$47.0M$198.0M$74.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA37.03
FCF Yield1.54%
Quick Ratio1.55
Interest Coverage—
Return 1Y-31.24%
Return 3Y296.25%
Return 5Y285.51%

Ownership

Insiders Held5.51%
Institutions Held70.35%
Institutions Float Held74.45%
Institutional HolderSharesReport Date
Blackrock Inc.26,337,1582026-03-31
Vanguard Portfolio Management LLC10,183,8132026-03-31
Vanguard Capital Management LLC9,339,7112026-03-31
Morgan Stanley8,889,0882026-03-31
State Street Corporation7,460,0232026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About HIMS

HIMS is led by CEO Andrew Dudum, employs 2,442 people, headquartered in San Francisco, US, publicly traded since 2019.

HIMS stock trades at $30.24 with a market capitalization of $6.75B. The stock is valued at a price-to-earnings (P/E) ratio of 44.00, price-to-book of 9.11, price-to-sales of 2.08. Over the past 52 weeks the stock has ranged between $13.74 and $70.43, and currently trades 57.1% below its 52-week high.

On profitability, HIMS generates a return on equity (ROE) of 23.66% — well above the market average, a sign of a high-quality business, return on capital employed of 19.59%, an operating margin of 4.51%, a net profit margin of -0.56%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides